Patent Yard Sign in
Canadian application, no grantCanada

2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage

CA 2419008 A1 · Owner: Kaken Pharmaceutical Co. Ltd. · Inventors: Ikegami, Satoru; Okuyama, Akihiko; Hoshina, Yoichiro

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

2,3-Diphenylpropionic acid derivatives of the general formula (1) or their salts; and medicines and cell adhesion inhibitors containing the derivatives , or the salts as the active ingredient: (1) wherein A B and C are each , independently hydrogen or a monovalent substituent; and X and X' are each independently hydrogen or a monovalent substituent.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 10, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 10, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 10, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 10, 2001
GrantedNo grant recorded
Term endedAugust 10, 2021
Patent numberCA 2419008 A1
Classification (IPC)C07C233/88 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedAug 10, 2001Term endedAug 10, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.